No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Monday, November 3, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Citi Maintains a Hold Rating on Salesforce (CRM), Cuts PT

by TheAdviserMagazine
5 months ago
in Business
Reading Time: 2 mins read
A A
Citi Maintains a Hold Rating on Salesforce (CRM), Cuts PT
Share on FacebookShare on TwitterShare on LInkedIn


In a report released on May 23, Tyler Radke from Citi maintained a Hold rating on Salesforce, Inc. (NYSE:CRM) and lowered its price target to $320 from $335. The rating comes ahead of the company’s Q1 2026 earnings release on May 28.

NYSE:CRM

A customer service team in an office setting using the company’s Customer 360 platform to communicate with customers.

The analyst reasoned that the overall demand for the company’s offerings is showing mixed signals. While interest in Agentforce, the company’s agentic AI platform, is strong, the analyst said its current impact is limited. The core CRM demand suggests variability, as some areas are undergoing a decline while others grow.

This can be seen in Salesforce, Inc.’s (NYSE:CRM) fiscal Q4 2025 results, where it surpassed EPS but fell short of revenue. It reported an EPS of $2.78 adjusted compared to the expected $2.61, while revenue was $9.99 billion compared to the expected $10.04 billion.

The analyst also said that the company is focusing on enhancing transparency and simplifying pricing. However, the effects of these initiatives are yet to materialize. Radke expects revenue growth for Salesforce, Inc. (NYSE:CRM) to remain in the high-single-digits. The top-of-funnel demand and overall engagement, however, appears weaker to him.

He is thus looking for more substantial data on commercialization and wider rollouts before adopting a more optimistic sentiment for the stock and its growth prospects.

While we acknowledge the potential of CRM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CRM and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best Debt Free IT Penny Stocks To Buy and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.



Source link

Tags: CitiCRMcutsholdmaintainsRatingSalesforce
ShareTweetShare
Previous Post

Texas Roadhouse: Steigende Gästezahlen beflügeln die Steakhouse-Kette!

Next Post

Before he revolutionized tech with Steve Jobs, Jony Ive wanted to quit Apple. Now he’s forging a new power pair with OpenAI’s Sam Altman

Related Posts

edit post
Hapoalim’s Bit app to pay 4% annual interest on deposits

Hapoalim’s Bit app to pay 4% annual interest on deposits

by TheAdviserMagazine
November 3, 2025
0

The zero interest rate on money lying in checking accounts is increasing pressure on the banks from both the...

edit post
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war

Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war

by TheAdviserMagazine
November 3, 2025
0

Pfizer has followed through on its threats, filing a lawsuit against both Metsera and Novo Nordisk during a M&A bidding...

edit post
Orchestra BioMed files secondary offering of ~8M shares (OBIO:NASDAQ)

Orchestra BioMed files secondary offering of ~8M shares (OBIO:NASDAQ)

by TheAdviserMagazine
November 3, 2025
0

Orchestra BioMed (OBIO) filed a prospectus to offer and sell from time to time ~8.03M shares by the selling stockholders....

edit post
India’s IPO boom signals market depth, but caution advised: Santosh Rao

India’s IPO boom signals market depth, but caution advised: Santosh Rao

by TheAdviserMagazine
November 3, 2025
0

India has emerged as the fourth-largest IPO market in the world, a milestone that reflects the growing depth and maturity...

edit post
Exclusive: Airwallex crosses  billion in annualized revenue as fintech unicorn takes on U.S. competitors like Ramp and Stripe

Exclusive: Airwallex crosses $1 billion in annualized revenue as fintech unicorn takes on U.S. competitors like Ramp and Stripe

by TheAdviserMagazine
November 3, 2025
0

As the fintech sector comes roaring back, companies like Ramp and Stripe have dominated headlines with eye-popping funding rounds and...

edit post
Fertilizer stocks poised for growth amid policy push: Siddhartha Khemka

Fertilizer stocks poised for growth amid policy push: Siddhartha Khemka

by TheAdviserMagazine
November 2, 2025
0

The market mood appears buoyant, but investors are treading cautiously across sectors. In an exclusive chat with ET Now, Siddhartha...

Next Post
edit post
Before he revolutionized tech with Steve Jobs, Jony Ive wanted to quit Apple. Now he’s forging a new power pair with OpenAI’s Sam Altman

Before he revolutionized tech with Steve Jobs, Jony Ive wanted to quit Apple. Now he’s forging a new power pair with OpenAI’s Sam Altman

edit post
These 7 penny stocks rally 10-30% in a week – Small but Mighty

These 7 penny stocks rally 10-30% in a week - Small but Mighty

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Another Violent Outburst – Democrats Inciting Civil Unrest

Another Violent Outburst – Democrats Inciting Civil Unrest

October 24, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Hapoalim’s Bit app to pay 4% annual interest on deposits

Hapoalim’s Bit app to pay 4% annual interest on deposits

0
edit post
Big Funds, Small Gains: Rethinking the Endowment Playbook

Big Funds, Small Gains: Rethinking the Endowment Playbook

0
edit post
Links 11/3/2025 | naked capitalism

Links 11/3/2025 | naked capitalism

0
edit post
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war

Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war

0
edit post
Colgate-Palmolive (CL) Q3 2025 Earnings: Key financials and quarterly highlights

Colgate-Palmolive (CL) Q3 2025 Earnings: Key financials and quarterly highlights

0
edit post
Hong Kong Pushes Tokenisation as Regulators Ease Rules on Crypto Assets

Hong Kong Pushes Tokenisation as Regulators Ease Rules on Crypto Assets

0
edit post
Hapoalim’s Bit app to pay 4% annual interest on deposits

Hapoalim’s Bit app to pay 4% annual interest on deposits

November 3, 2025
edit post
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war

Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war

November 3, 2025
edit post
Links 11/3/2025 | naked capitalism

Links 11/3/2025 | naked capitalism

November 3, 2025
edit post
How is Farm ERP Market Transforming the Future of Digital Agriculture?

How is Farm ERP Market Transforming the Future of Digital Agriculture?

November 3, 2025
edit post
Orchestra BioMed files secondary offering of ~8M shares (OBIO:NASDAQ)

Orchestra BioMed files secondary offering of ~8M shares (OBIO:NASDAQ)

November 3, 2025
edit post
1.8 Million Older Americans Die Like This Every Year. What Can You Do to Survive the 8 Top Causes of Death?

1.8 Million Older Americans Die Like This Every Year. What Can You Do to Survive the 8 Top Causes of Death?

November 3, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Hapoalim’s Bit app to pay 4% annual interest on deposits
  • Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war
  • Links 11/3/2025 | naked capitalism
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.